IEG Policy is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Joseph Harvey

London
As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Advertisement
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Zoetis, Virbac and Dechra show durability as H1 highlights impact of foreign exchange

Zoetis has outstripped its competitors during the first half of the year, with higher growth sales than any of the other billion-dollar businesses in animal health.

Financial Results Markets

Elanco and Bayer deal taps into emerging trends shaping a modern animal health sector

Elanco's pending purchase of Bayer Animal Health is a deal that capitalizes on industry trends that have emerged this year, claims chief executive Jeff Simmons.

Elanco Bayer Animal Health

Elanco to buy Bayer Animal Health in industry's largest-ever acquisition

Elanco has entered into an agreement to acquire Bayer's animal health division in a deal valued at around $7.6 billion.

Elanco Bayer Animal Health

GALVmed to help stimulate improved FMD vaccine for East Africa through AgResults project

The Global Alliance for Livestock Veterinary Medicines (GALVmed) will manage a competition that aims to encourage the development of an improved foot-and-mouth disease (FMD) vaccine for East Africa.

Foot and mouth disease Vaccines

Ex-IDEXX VP added to Zomedica board of directors

Diagnostics expert Johnny Powers has joined the Zomedica Pharmaceuticals board of directors.

People

Biotangents strikes partnership to improve on-farm infectious disease diagnostics

Scottish start-up Biotangents has entered a collaboration with local institutes to improve the accuracy of its point-of-care (POC) testing system for infectious diseases in livestock.

Bovine Diagnostics
See All
Advertisement
UsernamePublicRestriction

Register